Decorin, biglycan and their endocytosis receptor in rat renal cortex

Kidney International

Volumn 54, Issue 5, 1998, Pages 1529-1541

  Schaefer, Liliana ^a   Hausser, Heinz ^b   Altenburger, Martin ^b   Ugorcakova, Jana ^b   August, Christian ^b   Fisher, Larry W ^b   Schaefer, Roland M ^b   Kresse, Hans ^b  

^a Experimentelle Nephrologie   (Germany)

^b NONE

Author keywords

Glomerulosclerosis; Interstitial fibrosis; Small proteoglycan endocytosis receptor

Indexed keywords

BIGLYCAN; DECORIN; MESSENGER RNA; PROTEOGLYCAN; RECEPTOR PROTEIN; THY 1 ANTIGEN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOCYTOSIS; GLOMERULONEPHRITIS; GLOMERULOSCLEROSIS; GLOMERULUS CAPILLARY; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KIDNEY CORTEX; KIDNEY FIBROSIS; KIDNEY INTERSTITIUM; KIDNEY POLYCYSTIC DISEASE; KIDNEY TUBULE EPITHELIUM; MALE; NEPHRECTOMY; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

EID: 0031728023     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1998.00149.x     Document Type: Article

References (44)

1. BIANCO P, FISHER LW, YOUNG MF, TERMINE JD, GEHRON ROBEY P: Expression and localization of the two small proteoglycans biglycan and decorin in developing human skeletal and non-skeletal tissues. J Histochem Cytochem 38:1549-1563, 1990
2. WIGHT TN, HEINEGÅRD D, HASCALL VC: Proteoglycans: Structure and function, in Cell Biology of the Extracellular Matrix, edited by HAY ED, New York, Plenum Press, 1991. pp 45-78
3. KRESSE H, HAUSSER H, SCHÖNHERR E: Small proteoglycans. Experientia 49:403-416, 1993
4. IOZZO RV, MURDOCH RD: Proteoglycans of the extracellular environment: Clues from the gene and protein side offer novel perspectives in molecular diversity and function. FASEB J 10:598-614, 1996
5. SANTRA M, MANN DM, MERCER EW, SKORSKI T, CALABRETTA B, IOZZO RV: Ectopic expression of decorin protein core causes generalized growth suppression in neoplastic cells of various histogenetic origin and requires endogenous p21, an inhibitor of cyclin-dependent kinases. J Clin Invest 100:149-157, 1997
6. DANIELSON KG, BARIBAULT H, HOLMES DF, GRAHAM H, KADLER K, LOZZO RV: Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility. J Cell Biol 136:729-743, 1997
7. SCHÖNHERR E, WITSCH-PREHM P, HARRACH B, ROBENEK H, RAUTERBERG J, KRESSE H: Interaction of biglycan with type I collagen. J Biol Chem 270:2776-2783, 1995
8. YAMAGUCHI Y, MANN DM, RUOSLAHTI E: Negative regulation of transforming growth factor-β by the proteoglycan decorin. Nature 346:281-284, 1990
9. HILDEBRAND A, ROMARIS M, RASMUSSEN LM, HEINEGARD D, TWARDZIK DR, BORDER WA, RUOSLAHTI E: Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor-β. Biochem J 302:527-534, 1994
10. HAUSSER H, GRÖNING A, HASILIK A, SCHÖNHERR E, KRESSE H: Selective inactivity of TGF-β/decorin complexes. FEBS Lett 353:243-245, 1994
11. TAKEUCHI Y, KODAMA Y, MATSUMOTO T: Bone matrix decorin binds transforming growth factor-β and enhances its bioactivity. J Biol Chem 269:32634-32638, 1994
12. HAUSSER H, HOPPE W, RAUCH U, KRESSE H: Endocytosis of small dermatan sulphate proteoglycan. Identification of binding proteins. Biochem J 263:137-142, 1989
13. HAUSSER H, OBER B, QUENTIN-HOFFMANN E, SCHMIDT G, KRESSE H: Endocytosis of different members of the small chondroitin/dermatan sulfate proteoglycan family. J Biol Chem 267:11559-11564, 1992
14. HAUSSER H, KRESSE H: Binding of heparin and of the small proteoglycan decorin to the same endocytosis receptor protein leads to different metabolic consequences. J Cell Biol 115:45-52, 1991
15. HAUSSER H, SCHÖNHERR E, MÜLLER M, LISZIO C, ZHAO BIN, FISHER LW, KRESSE H: Receptor-mediated endocytosis of decorin: Involvement of leucine-rich repeat structures. Arch Biochem Biophys 349: 363-370, 1998
16. HAUSSER H, WITT O, KRESSE H: Influence of membrane-associated heparan sulfate on the internalization of the small proteoglycan decorin. Exp cell Res 208:398-406, 1993
17. HAUSSER H, WEDEKIND P, SPERBER T, PETERS R, HASILIK A, KRESSE H: Isolation and cellular localization of the decorin endocytosis receptor, Eur J Cell Biol 71:325-331, 1996
18. KRESSE H, ROSTHOJ S, QUENTIN E, HOLLMANN J, GLÖSSL J, OKADA S, TONNESEM T: Glycosaminoglycan-free small proteoglycan core protein is secreted by fibroblasts from a patient with a syndrome resembling progeroid. Am J Hum Gen 41:436-453, 1987
19. QUENTIN-HOFFMANN E, HARRACH B, ROBENEK H, KRESSE H: Proteoglycan metabolism in health and disease. Jpn J Inherited Metabolic Dis 9:21-28, 1993
20. BORDER WA, NOBLE NA: Transforming growth factor beta in tissue fibrosis. N Engl J Med 331:1286-1292, 1994
21. BORDER WA, NOBLE NA: TGF-β in kidney fibrosis: A target for gene therapy. Kidney Int 51:1388-1396, 1997
22. OKUDA S, LANGUINO LR, RUOSLAHTI E, BORDER WA: Elevated expression of transforming growth factor-β and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial extracellular matrix. J Clin Invest 86:453-462, 1990
23. BORDER WA, NOBLE NA, YAMAMOTO T, HARPER JR, YAMAGUCHI Y, PIERSCHBACHER MD, RUOSLAHTI E: Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease. Nature 360:361-364, 1992
24. ISAKA Y, BREES DK, JKEGAYA K, KANEDA Y, IMAI E, NOBLE NA, BORDER WA: Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney. Nature Med 2:418-423, 1996
25. DIAMOND JR, LEVINSON M, KREISBERG R, RICARDO SD: Increased expression of decorin in experimental hydronephrosis. Kidney Int 51:1133-1139, 1997
26. BRANDIS A, BIANCHI G, REALE E, HELMCHEN U, KUHN K: Age-dependent glomerulosclerosis and proteinuria occurring in rats of the Milan normotensive strain and not in rats of the Milan hypertensive strain. Lab Invest 55:234-243, 1986
27. SCHÄFER K, GRETZ N, BADER M, OBERBÄUMER J, ECKARDT KU, KRITZ W, BACHMANN S: Characterization of the Han:SPRD rat model for hereditary polycystic kidney disease. Kidney Int 46:134-152, 1994
28. GRETZ N, WALDHERR R, STRAUCH M: The remnant kidney model, in Chronic Renal Failure, edited by GRETZ N, STRAUCH M, Basel, Karger, 1993, pp 1-28
29. SPIRO RG: Studies on the renal glomerular basement membrane. Preparation and chemical composition. J Biol Chem 242:1915-1919, 1984
30. WITSCH P, KRESSE H, GRESSNER AM: Biosynthesis of small proteoglycans by hepatic lipocytes in primary culture. FEBS Lett 258:233-235, 1989
31. FISHER LW, STUBBS JD, YOUNG MF: Antisera and cDNA probes to human and certain animal model bone matrix noncollagenous proteins. Acta Orthop Scand 266(Suppl):61-65, 1995
32. SCHMIDT G, ROBENEK H, HARRACH B, GLÖSSL J, NOLTE V, HÖRMANN H, RICHTFR H, KRESSE H: Interaction of small dermatan sulfate proteoglycans from fibroblasts with fibronectin. J Cell Biol 104:1683-1691, 1987
33. CORDELL JL, FALINI B, ERBER WN, GHOSH AK, ABDULAZIZ Z, MACDONALD S, PULFORD KAF, STEIN H, MASON DY: Immunoenzymatic labelling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatse (APAAP complexes). J Histochem Cytochem 32:219-229, 1984
34. SCHAEFER L, HAN X, GRETZ N, HÄENER C, MEIER K, MATZKIES F, SCHAEFER RM: Tubular gelatinase A (MMP-2) and its tissue inhibitors in polycystic kidney disease in the Han:SPRD rat. Kidney int 49:75-81, 1996
35. ASUNDI VK, DREHER KL: Molecular characterization of vascular smooth muscle decorin: Deduced core protein structure and regulation of gene expression. Eur J Cell Biol 59:314-321, 1992
36. WEGROWSKI Y, PILLARISETTI J, DANIELSON KG, SUZUKI S, IOZZO RV: The murine biglycan: Complete cDNA cloning, genomic organization, promoter function, and expression. Genomics 30:8-17, 1995
37. FISHER LW, TERMINE DJ, YOUNG MF: Deduced protein sequence of bone small proteoglycan I (biglycan) shows homology with proteoglycan II (decorin) and several nonconnective tissue proteins in a variety of species. J Biol Chem 264:4571-4576, 1989
38. MILLER MA, KOLB PE, RASKIND MA: A method for simultaneous detection of multiple mRNAs using digoxigenin and radioisotopic cRNA probes. J Histochem Cytochem 41:1741-1750, 1993
39. KRESSE H, Liszio C, SCHÖNHERR E, FISHER LW: Critical role of glutamate in a central leucine-rich repeat of decorin for interaction with type I collagen. J Biol Chem 272:18404-18410, 1997
40. Voss B, GLÖSSL J, CULLY Z, KRESSE H: Immunocytochemical investigation on the distribution of small chondroitin sulfate/dermatan sulfate proteoglycan in the human. J Histochem Cytochem 34:1013-1019, 1986
41. BREES DK, IKEGAYA N, KETTELER M, NOBLE NA, BORDER WA: Deficiency of the TGF-β antagonist, decorin, precedes matrix deposition in experimental glomerulonephritis. (abstract) J Am Soc Nephrol 5:801, 1994
42. JäRVELÄINEN HT, KINSELLA MG, WIGHT TN, SANDELL LJ: Differential expression of small chondroitin/dermatan sulfate proteoglycan PGI/biglycan and PGH/decorin by vascular smooth muscle cells and endothelial cells in culture. J Biol Chem 266:23274-23281, 1991
43. VLEMING LJ, BAELDE JJ, WESTENDORP RGJ, DAHA MR, VAN ES LA, BRUIJN JA: Progression of chronic renal disease in humans is associated with the deposition of basement membrane components and decorin in the interstitial extracellular matrix, Clin Nephrol 44:211-219, 1995
44. NIEMIR ZI, STEIN H, NORONHA IL, KRÜGER C, ANDRASSY K, RITZ E, WALDHERR R: PDGF and TGF-β contribute to the natural course of human IgA glomerulonephritis. Kidney Int 48:1530-1541, 1995